Albemarle Q3 sales fall 3.5% to $1.3 billion; net loss of $161 million after impairment
Albemarle reported third-quarter 2025 net sales of $1.3 billion, down 3.5% from a year earlier, mainly on lower Energy Storage pricing. The company posted a net loss of $161 million, or $1.72 per diluted share, which includes a non-cash goodwill impairment charge tied to Ketjen, but adjusted EBITDA rose 7% to $226 million and management said full-year 2025 results are now expected toward the higher end of its $9/kg lithium price scenario ranges, which matters to shareholders because it signals a stronger expected year despite the charge.
Key points
- Net sales were $1.3 billion, down 3.5% from $1.35 billion in the third quarter of 2024; Energy Storage pricing fell 16% while volumes rose 8%.
- Net loss attributable to Albemarle was $161 million, or $1.72 per diluted share, including a $181 million goodwill impairment charge associated with Ketjen.
- Adjusted EBITDA was $226 million, up 7%; adjusted loss was $0.19 per diluted share versus $1.55 a year earlier.
- Full-year 2025 outlook was enhanced toward the higher end of the $9/kg scenario ranges, capital expenditures are now expected at about $600 million, and positive free cash flow of $300 million to $400 million is expected.
The filing
Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.